Response to: Comments to: Management of diabetic macular edema patients in clinical practice in Spain

Abstract

Get full access to this article

View all access options for this article.

References

Wells

Glassman

Ayala

, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial. Ophthalmology 2016; 123(6): 1351–1359.

Xiong

Pigeolet

Mulyukov

, et al. Dose-response analysis of ranibizumab as-needed regimens for visual improvement in patients with diabetic macular edema using a modelling approach. Contemp Clin Trials 2019; 80: 34–39.